Form 13-F position report

ODONATE THERAPEUTICS INC COM (

Reported by STATE STREET CORPORATION

ODT CUSIP 676079106 Manager CIK 0000093751

Reported 0 shares, down 85,538 (100.0%) from the prior quarter.

Reported value -100.0%; share count -100.0% vs. the prior quarter.

Reduced
% of reported 13F value 0 This manager · Q1 2022
Shares 0 Quarter-end amount reported
Reported value $0 Fair value at quarter end
Consecutive quarters held 17 Through Q1 2022

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2021-12-31 115000
2022-03-31 0

Quarterly position history

How this manager's reported quarter-end position changed over time.

2 quarters
Quarterly reported position history for ODONATE THERAPEUTICS INC COM ( held by STATE STREET CORPORATION.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q1 2022 Reduced 0 -85,538 (-100.0%) 0 $0 2022-05-16
Q4 2021 Reduced 85,538 -17,865 (-17.3%) < 0.01% $115,000 2022-02-14
Five years are shown. A free account unlocks the complete reported history. Unlock full history

Who else reported the position

50 managers reported ODONATE THERAPEUTICS INC COM ( for Q1 2022.

Managers reporting ODONATE THERAPEUTICS INC COM ( in Q1 2022.
Manager Activity Shares Change % of reported 13F Reported value Tenure
Boxer Capital LLC Unchanged 4,207,086 0 0.29% $5,553,000 18 qtrs
Samsara BioCapital LLC Unchanged 700,421 0 0.23% $925,000 14 qtrs
ACADIAN ASSET MANAGEMENT LLC Reduced 384,995 -31,744 < 0.01% $506,000 5 qtrs
Hennion & Walsh Asset Management Inc Reduced 69,264 -3,486 < 0.01% $91,000 5 qtrs
Tower Research Capital LLC TRC Reduced 43,163 -2,607 < 0.01% $57,000 9 qtrs
SIMPLEX TRADING LLC Reduced 2,000 -6,982 < 0.01% $2,000 8 qtrs
XTX Topco Ltd Reduced 0 -11,714 0 $0 2 qtrs
Engineers Gate Manager LP Reduced 0 -18,822 0 $0 7 qtrs
GEODE CAPITAL MANAGEMENT LLC Reduced 0 -352,814 0 $0 17 qtrs
RENAISSANCE TECHNOLOGIES LLC Reduced 0 -171,349 0 $0 3 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
March 31, 2022
Filed
May 16, 2022
Filing type
13F-HR
Position type
COM

Voting authority reported

No voting-authority amounts were reported for this position. Voting authority is not required for reported call options.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.